JP2021526802A - 多株集団制御系および方法 - Google Patents

多株集団制御系および方法 Download PDF

Info

Publication number
JP2021526802A
JP2021526802A JP2020567889A JP2020567889A JP2021526802A JP 2021526802 A JP2021526802 A JP 2021526802A JP 2020567889 A JP2020567889 A JP 2020567889A JP 2020567889 A JP2020567889 A JP 2020567889A JP 2021526802 A JP2021526802 A JP 2021526802A
Authority
JP
Japan
Prior art keywords
toxin
strain
bacterial strain
bacterial
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020567889A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021526802A5 (https=
Inventor
ヘイスティ，ジェフ
ユリウス リャオ，マイケル
オマール ディン，ムハンマド
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
University of California San Diego UCSD
Original Assignee
University of California
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, University of California San Diego UCSD filed Critical University of California
Publication of JP2021526802A publication Critical patent/JP2021526802A/ja
Publication of JP2021526802A5 publication Critical patent/JP2021526802A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P39/00—Processes involving microorganisms of different genera in the same process, simultaneously
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185—Escherichia
    • C12R2001/19—Escherichia coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2020567889A 2018-06-08 2019-06-07 多株集団制御系および方法 Pending JP2021526802A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862682755P 2018-06-08 2018-06-08
US62/682,755 2018-06-08
PCT/US2019/036179 WO2019237083A1 (en) 2018-06-08 2019-06-07 Multistrain population control systems and methods

Publications (2)

Publication Number Publication Date
JP2021526802A true JP2021526802A (ja) 2021-10-11
JP2021526802A5 JP2021526802A5 (https=) 2022-05-23

Family

ID=68770625

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020567889A Pending JP2021526802A (ja) 2018-06-08 2019-06-07 多株集団制御系および方法

Country Status (6)

Country Link
US (2) US11896626B2 (https=)
EP (1) EP3801582A4 (https=)
JP (1) JP2021526802A (https=)
CN (1) CN112601536B (https=)
CA (1) CA3102955A1 (https=)
WO (1) WO2019237083A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102562275B1 (ko) * 2023-03-07 2023-07-31 천준영 미세조류의 생화학적 봉쇄 방법 및 이를 적용한 유전자 조작된 미세조류 이용 하폐수 정화 방법
KR102575631B1 (ko) * 2023-03-07 2023-09-06 천준영 미세조류 생화학적 봉쇄 방법

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107709558B (zh) 2015-04-09 2022-05-13 加利福尼亚大学董事会 用于治疗物的产生和释放的工程化细菌
EP3801582A4 (en) * 2018-06-08 2022-07-06 The Regents of the University of California SYSTEMS AND METHODS FOR REGULATING MULTI-STRAINS POPULATIONS
WO2021119436A1 (en) * 2019-12-13 2021-06-17 The Regents Of The University Of California Compositions and methods of using inducible signaling for tunable dyanmics in microbial communities
EP4724111A2 (en) * 2023-06-08 2026-04-15 The Trustees Of Columbia University In The City Of New York Intracellular delivery of therapeutic cargos and viral rnas by engineered salmonella

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016164636A1 (en) * 2015-04-09 2016-10-13 The Regents Of The University Of California Engineered bacteria for production and release of therapeutics

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196318A (en) 1990-06-26 1993-03-23 The Texas A&M University System Precisely regulated expression of deleterious genes
JP2003532698A (ja) * 2000-05-10 2003-11-05 プリンストン ユニバーシティ 細菌の増殖および病理発生を調節するための化合物ならびに方法
US8858930B2 (en) * 2004-10-26 2014-10-14 Chengru Zhu Live attenuated bacterial vaccine to reduce or inhibit carriage and shedding of enterohemorrhagic Escherichia coli in cattle
EP1655370A1 (en) 2004-11-05 2006-05-10 Gesellschaft für Biotechnologische Forschung Bacterial vector
WO2008045333A2 (en) 2006-10-05 2008-04-17 Tyco Healthcare Group Lp Flexible endoscopic stitching devices
EP2114992A2 (en) * 2007-01-09 2009-11-11 Yissum Research Development Company, of The Hebrew University of Jerusalem Anti-bacterial peptides and methods of treating diseases using same
WO2010022260A2 (en) * 2008-08-20 2010-02-25 University Of Medicine And Dentistry Of New Jersey Novel toxin-antitoxin system
EP2182068A1 (en) 2008-10-28 2010-05-05 DKFZ Deutsches Krebsforschungszentrum Use of bacteria for the sensing and killing of cancer cells
CN201362719Y (zh) 2009-01-15 2009-12-16 北京航空航天大学 一种实现细胞间振荡子同步的电路结构
JP5612269B2 (ja) * 2009-04-24 2014-10-22 花王株式会社 歯周病マーカー
WO2011150421A2 (en) 2010-05-28 2011-12-01 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium to decrease tumor growth
US8942321B2 (en) 2010-09-22 2015-01-27 Qualcomm Incorporated Efficient compressed sensing channel estimation for single-carrier communication systems
WO2013003597A1 (en) * 2011-06-30 2013-01-03 Exxonmobil Research And Engineering Company Regulation of toxin and antitoxin genes for biological containment
US9603877B2 (en) 2011-08-31 2017-03-28 Nanyang Technological University Isolated nucleotide molecule and method of sensing and killing of pathogenic microorganism
US9044020B2 (en) 2011-08-31 2015-06-02 Nanyang Technological University Isolated nucleotide molecule and method of sensing and killing of pathogenic microorganism
CA2884816A1 (en) 2012-09-13 2014-03-20 Massachusetts Institute Of Technology Programmable drug delivery profiles of tumor-targeted bacteria
SE537235C2 (sv) 2012-09-21 2015-03-10 Valeas Recycling Ab Förfarande och arrangemang för återvinning av förångningsbara ämnen ur en slagg medelst plasmainducerad förångning
WO2014098767A1 (en) 2012-12-21 2014-06-26 Nanyang Technological University Programmable synthetic lysis system for controlled release of macromolecules
US9593339B1 (en) * 2013-02-14 2017-03-14 David Gordon Bermudes Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment
KR20210100224A (ko) * 2014-04-15 2021-08-13 에이오바이오미 엘엘씨 암모니아-산화 니트로소모나스 유트로파 균주 d23
KR101647491B1 (ko) 2014-06-25 2016-08-11 전남대학교산학협력단 유도자 불요구성 자가세포농도 인식 자가 유도시스템 및 그의 용도
CN104131018A (zh) 2014-07-31 2014-11-05 厦门大学 一种细胞内蛋白自诱导表达的方法
IL294171A (en) * 2016-05-25 2022-08-01 Mybiotics Pharma Ltd Composition and methods for microbiota therapy
US20210284953A1 (en) 2017-05-19 2021-09-16 The Regents Of The University Of California Synthetic quorum-regulated lysis
EP3801582A4 (en) * 2018-06-08 2022-07-06 The Regents of the University of California SYSTEMS AND METHODS FOR REGULATING MULTI-STRAINS POPULATIONS
WO2021119436A1 (en) 2019-12-13 2021-06-17 The Regents Of The University Of California Compositions and methods of using inducible signaling for tunable dyanmics in microbial communities

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016164636A1 (en) * 2015-04-09 2016-10-13 The Regents Of The University Of California Engineered bacteria for production and release of therapeutics

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
NATURE, vol. 420, JPN6023026094, 2002, pages 224 - 230, ISSN: 0005092138 *
NATURE, vol. 536, JPN6023026095, 2016, pages 81 - 85, ISSN: 0005092137 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102562275B1 (ko) * 2023-03-07 2023-07-31 천준영 미세조류의 생화학적 봉쇄 방법 및 이를 적용한 유전자 조작된 미세조류 이용 하폐수 정화 방법
KR102575631B1 (ko) * 2023-03-07 2023-09-06 천준영 미세조류 생화학적 봉쇄 방법

Also Published As

Publication number Publication date
CA3102955A1 (en) 2019-12-12
US11896626B2 (en) 2024-02-13
CN112601536B (zh) 2024-01-09
US20240350559A1 (en) 2024-10-24
US20210169941A1 (en) 2021-06-10
EP3801582A4 (en) 2022-07-06
EP3801582A1 (en) 2021-04-14
WO2019237083A1 (en) 2019-12-12
CN112601536A (zh) 2021-04-02

Similar Documents

Publication Publication Date Title
US20240350559A1 (en) Multistrain population control systems and methods
JP7076111B2 (ja) 治療剤の製造および放出のための遺伝子操作された細菌
US20230126966A1 (en) Synthetic quorum-regulated lysis
Falcone et al. The small RNA ErsA of Pseudomonas aeruginosa contributes to biofilm development and motility through post-transcriptional modulation of AmrZ
Zhang et al. QsvR and OpaR coordinately repress biofilm formation by Vibrio parahaemolyticus
Chowdhury et al. Fitness costs of antibiotic resistance impede the evolution of resistance to other antibiotics
Makowski et al. Dynamics of chromosome replication and its relationship to predatory attack lifestyles in Bdellovibrio bacteriovorus
Dwidar et al. Controlling Bdellovibrio bacteriovorus gene expression and predation using synthetic riboswitches
Müller et al. Generation and isolation of target-specific single-domain antibodies from shark immune repertoires
McKenna et al. Engineered sigma factors increase full-length antibody expression in Escherichia coli
Gaffke et al. Differential chromosome-and plasmid-borne resistance of Escherichia coli hfq mutants to high concentrations of various antibiotics
Cheng et al. Efficient plasmid transfer via natural competence in a microbial co‐culture
Krawczyk-Balska et al. RNA-Mediated control in listeria monocytogenes: insights into regulatory mechanisms and roles in metabolism and virulence
Patel et al. Synthetic small RNAs: Current status, challenges, and opportunities
Baaziz et al. Bacterial resistance to temperate phage is influenced by the frequency of lysogenic establishment
US12503704B2 (en) Modified cell
Al-Ramahi et al. ssDNA recombineering boosts in vivo evolution of nanobodies displayed on bacterial surfaces
Hao et al. The pIT5 plasmid series, an improved toolkit for repeated genome integration in E. Coli
WO2021119436A1 (en) Compositions and methods of using inducible signaling for tunable dyanmics in microbial communities
Morón et al. Rli51 attenuates transcription of the Listeria pathogenicity island 1 gene mpl and functions as a trans-acting sRNA in intracellular Bacteria
Baas-Thomas et al. Characterization of ColE1 production for robust tolC plate dual-selection in E. coli
Mukherjee et al. Production of an anti‐Candida peptide via fed batch and ion exchange chromatography
US20240132880A1 (en) Transcriptional programming in a bacteroides consortium
Dhaouadi Optogenetic Control of Bacterial Dormancy
Herynek Optimization of recombinant protein production in E. coli expression system by genetic engineering methods

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220513

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220513

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230627

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230921

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231124

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20231212

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240411

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20240529

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20240726